Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients.

导出 OA

翻译打印收藏纠错

作者： Silvia,Belluti ^[1] ; Valentina,Semeghini ^[1] ; Giovanna,Rigillo ^[1] ; Mirko,Ronzio ^[2] ; Daniela,Benati ^[3] ; Federica,Torricelli ^[4] ; Luca,Reggiani Bonetti ^[5] ; Gianluca,Carnevale ^[6] ; Giulia,Grisendi ^[7] ; Alessia,Ciarrocchi ^[4] ; Massimo,Dominici ^[7] ; Alessandra,Recchia ^[3] ; Diletta,Dolfini ^[2] ; Carol,Imbriano ^[8]

作者单位： Department of Life Sciences, University of Modena and Reggio Emilia, via Campi 213/D, Modena, Italy. ^[1] Department of Biosciences, University of Milan, Milan, Italy. ^[2] Centre for Regenerative Medicine, Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy. ^[3] Laboratory of Translational Research, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy. ^[4] Department of Medical and Surgical Sciences for Children & Adults, Division of Pathology, University-Hospital of Modena and Reggio Emilia, Modena, Italy. ^[5] Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy. ^[6] Laboratory of Cellular Therapy, Program of Cell Therapy and Immuno-Oncology, Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy. ^[7] Department of Life Sciences, University of Modena and Reggio Emilia, via Campi 213/D, Modena, Italy. carol.imbriano@unimore.it. ^[8]

关键词 Alternative splicing Genome editing NF-Y Prostate cancer Transcriptome profiling